As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Life expectancy and the number of elderly people are progressively increasing around the world. Together with other pathologies, allergic diseases also show an increasing incidence in geriatric age.
This review provides the state of the art on the physiological changes in the elderly responsible for allergic diseases, their biological characteristics and the major immunological and extra immunological mechanisms.
Aims and scope
Clinical and Molecular Allergy is an open access, peer-reviewed journal that covers all aspects of allergy research with a special focus on molecular allergy and clinical applications of molecular techniques. Clinical and Molecular Allergy is the official journal of the Italian Society of Allergology, Asthma and Clinical Immunology.
This international journal appeals to allergists & immunologists, pulmonologists, otolaryngologists, geneticists and other physicians, healthcare workers, medical students and the public worldwide.
The journal accepts research articles, reviews, commentaries, case reports and correspondence and has six different sections.
Enrico Maggi, University of Firenze, Italy
Giovanni Passalacqua, University of Genoa, Italy
Diego Bagnasco, University of Genoa, Italy
Cristoforo Incorvaia, Gaetano Pini CTO Hospital, Italy
Luigi Macchia, University of Bari, Italy
Marina Mauro, Azienda Sanitaria Locale della provincia di Como, Italy
Allergy & Digital Medicine
Fabiana Furci, Clinica di Messina, Italy
Giovanni Paoletti, Humanitas University, Italy
Roberto Paganelli, Università degli studi "G. d'Annunzio", Italy
Alessandra Vultaggio, Careggi University Hospital, Italy
Sebastiano Gangemi, Messina University Hospital, Italy
Massimo Triggiani, University of Salerno, Italy
Food and Drug Allergy
Anthi Rogkakou, UOC Allergologia Ospedale Policlinico San Martino, Italy
Oliviero Rossi, University of Firenze, Italy
Giovanni Melioli University of Genova, Italy
Eleonora Savli, Guglielmo da Saliceto Hospital, Italy
Marco Caminati, Medico Università Ospedale di Verona Centro, Italy
Vincenzo Patella, ASL Salern, Italy
Andrea Matucci, Fondazione Salvatore Maugeri, Italy
Eustachio Nettis, University of Bari, Italy
Translational Allergy and Immunity
Maria Rosaria Galdiero, Università degli Studi di Napoli Federico II, Italy
Paola Parronchi, University of Firenze, Italy
About the SIAAIC
The Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) is a scientific society strongly represented on the national territory with more than 650 active members working in university structures, hospital departments and territorial outpatients' clinics.
The main aim of SIAAIC is to improve allergy and clinical immunology as a discipline, through integrated actions of specialistic and post-specialistic education, promotion of knowledge in allergy and clinical immunology, and support of patients' organizations. These aspects are accomplished by giving the opportunity to its members (a third of which are Junior Members, under 35 years of age) to attend several educational events, participate in clinical/epidemiological research and patients-targeted informative events.
Moreover, many active SIAAIC members are worldwide well-known scientists and contribute to increase the knowledge in allergy and clinical immunology into the international scientific community.
The official journal of the Italian Society of Allergology, Asthma and Clinical Immunology (SIAAIC)
Annual Journal Metrics
99 days to first decision for reviewed manuscripts only
94 days to first decision for all manuscripts
157 days from submission to acceptance
23 days from acceptance to publication
315 Altmetric mentions